Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzo Biochem Inc (NYSE:ENZ)

6.58
Delayed Data
As of Feb 23
 -0.08 / -1.20%
Today’s Change
4.00
Today|||52-Week Range
7.51
-5.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues24.6M26.4M26.6M26.3M
 
 
 
 
 
Cost of Goods Sold12.8M14.0M13.5M13.3M
 
 
 
 
 
Depreciation And Amortization952.0K960.0K978.0K927.0K
 
 
 
 
 
 
Operating ExpensesGross Income10.8M11.4M12.1M12.1M
 
 
 
 
 
General Expenses15.0M14.0M13.5M13.3M
 
 
 
 
 
Research And Development861.0K882.0K914.0K822.0K
 
 
 
 
 
Total Operating Expenses28.8M28.9M28.0M27.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.2M-2.5M-1.4M-1.3M
 
 
 
 
 
Extraordinary Credit11.7M0.0038.8M0.00
 
 
 
Interest Expense On Debt42.0K40.0K14.0K--
 
 
 
 
Other Expenses-377.0K441.0K-340.0K-242.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income7.0M-2.1M37.1M-1.5M
 
 
 
 
 
Income Taxes-207.0K-2.0K-933.0K-20.0K
 
 
 
 
 
Net Income6.8M-2.1M36.1M-1.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS46.1M46.2M46.3M46.3M
 
 
 
 
 
Shares To Calculate EPS Diluted46.5M46.2M46.7M46.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.15-$0.05$0.77-$0.03
 
 
 
 
 
EPS Diluted$0.15-$0.05$0.77-$0.03